Skip to content

Urine Biomarker for Kidney Transplant Rejection

An Adaptive Sample Collection to Evaluate a Biomarker for Kidney Transplant Rejection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05072951
Enrollment
750
Registered
2021-10-11
Start date
2021-10-31
Completion date
2025-10-31
Last updated
2021-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graft Rejection

Brief summary

An adaptive sample collection to support biomarker evaluation for kidney transplant rejection.

Interventions

DIAGNOSTIC_TESTUrine Biomarker for Kidney Transplant Rejection

Biomarker for active kidney transplant rejection.

Sponsors

Exosome Diagnostics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Ability to provide informed consent * Kidney Transplant

Exclusion criteria

* Pediatric patients, under 18 years of age

Design outcomes

Primary

MeasureTime frame
Biospecimen collection3 years after last enrollment

Contacts

Primary ContactSonia Kumar, PhD
Sonia.Kumar@bio-techne.com7816939600

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026